| News releases from BioMedReports |  |
Imprimis Rising: Unique Pathway Requires Fewer and Smaller Clinical Trials
Source: Marketwired News Releases
May 08, 2013 07:10 AM
Pluristem Carving Out Distinct Niche in Orthopedic Medicine With New Clinical Trials in Rotator Cuff Repair
Source: Marketwired News Releases
May 08, 2013 07:01 AM
Tauriga Sciences' CEO Pulls Off Impressive Turnaround; More to Come?
Source: Marketwired News Releases
May 07, 2013 09:54 AM
Bullish $10 Million Bet Placed by CRO After CEL-SCI Acts to Accelerate Phase III Enrollment
Source: Marketwired News Releases
April 24, 2013 07:01 AM
Boston Therapeutics Addressing Unmet Medical Needs by Harnessing Complex Carbohydrate Chemistry
Source: Marketwired News Releases
April 22, 2013 07:01 AM
CEL-SCI's Price Rebound Looks Strong
Source: Marketwired News Releases
April 04, 2013 07:01 AM
AntriaBio Set for a Major Short Squeeze
Source: Marketwired News Releases
March 14, 2013 11:48 AM
Once-a-Week Insulin Shot Could Help Growing Diabetes Patient Base and Spell Huge Profits for Investors
Source: Marketwired News Releases
February 22, 2013 07:22 AM
Cyclacel Pharmaceuticals Looks Undervalued Given Potential Frontline Leukemia Drug
Source: Marketwired News Releases
February 21, 2013 05:05 AM
Orphan Drug Catalyst Pushing DARA Shares Toward Possible Technical Break-Out
Source: Marketwired News Releases
February 19, 2013 08:06 AM
Pozen: An Undervalued Investment and Catalyst Trade Opportunity
Source: Marketwired News Releases
February 11, 2013 08:00 AM
Three Upcoming Biopharma Catalyst Trades to Consider
Source: Marketwired News Releases
February 06, 2013 07:53 AM
Sunshine's Short Squeeze Play Warms Bullish Investors
Source: Marketwired News Releases
February 06, 2013 07:28 AM
Reducing 'Bad' LDL Cholesterol by Silencing Disease Causing Genes
Source: Marketwired News Releases
February 04, 2013 08:09 PM
Under Appreciated Tekmira Starting to Bounce May Head Higher as Sector Heats Up
Source: Marketwired News Releases
January 31, 2013 08:22 AM
Novel Alzheimer's Therapeutics Developer Says Investors Should Remain Undeterred Despite Disappointing Results From Major Phase 3 Trials
Source: Marketwired News Releases
January 30, 2013 08:07 AM
Celsion -- A Simple Model to Determine Fair Value
Source: Marketwired News Releases
January 29, 2013 09:01 AM
EnteroMedics' Late Stage Treatment Takes on Obesity Epidemic
Source: Marketwired News Releases
January 29, 2013 07:01 AM
Is MMR Global's Personal Health Records Patent Portfolio Worth a Closer Look?
Source: Marketwired News Releases
January 23, 2013 08:01 AM
Athersys: Short Term Catalyst With Long Term Potential
Source: Marketwired News Releases
January 22, 2013 07:25 AM
Rumors, News and Biotech Buzz Present Various Trade Opportunities
Source: Marketwired News Releases
January 18, 2013 07:01 AM
Closer Look: BioLineRx's Multi Billion Dollar Schizophrenia Drug
Source: Marketwired News Releases
January 15, 2013 07:01 AM
Anticipating Neptune's Big Bounce to Continue
Source: Marketwired News Releases
January 15, 2013 07:01 AM
Smart Investors Spot Profitable Upside in Neptune's Recovery Plan
Source: Marketwired News Releases
December 19, 2012 07:12 AM
Near Term Catalyst Has ArQule Poised for a Move Up
Source: Marketwired News Releases
December 18, 2012 11:40 AM
Report Focuses on NovaBay Pharmaceuticals' Diverse Pipeline and Multiple Upcoming Catalysts
Source: Marketwired News Releases
September 06, 2012 08:28 AM
Developer of New Treatment for Severe Asthma Episodes Expects Phase 2 Clinical Trial Results Soon
Source: Marketwired News Releases
April 19, 2012 01:39 PM
Chairman & CEO of TapImmune Says Licensed HER2/neu Antigen Technology Is a Game Changer
Source: Marketwired News Releases
April 17, 2012 09:13 AM
Exclusive Video Q&A With Timothy M. Mayleben, CEO of Aastrom Biosciences
Source: Marketwired News Releases
April 09, 2012 10:45 AM
Exclusive Video Q&A With Sijmen de Vries, CEO of Pharming
Source: Marketwired News Releases
April 04, 2012 07:53 AM
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here